Coloplast A/S Class B logo

Coloplast A/S Class B (CBHD)

Market Open
11 Aug, 06:14
57. 52
+0.26
+0.4541%
- Market Cap
- P/E Ratio
9.27% Div Yield
10 Volume
- Eps
57.26
Previous Close
Add Transaction
Day Range
57.52 57.52
Year Range
49.67 85.92
Want to track CBHD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

CBHD trading today higher at €57.52, an increase of 0.4541% from yesterday's close, completing a monthly increase of 15.2474% or €7.61. Over the past 12 months, CBHD stock lost -21.9327%.
CBHD is not paying dividends to its shareholders.
The last earnings report, released on May 12, 2026, missed the consensus estimates by -5.92%. On average, the company has fell short of earnings expectations by -3.0291%, based on the last three reports.
Coloplast A/S Class B has completed 1 stock splits, with the recent split occurring on Dec 19, 2012.
The company's stock is traded on 9 different exchanges and in various currencies, with the primary listing on LSE (DKK).

CBHD Chart

Coloplast A/S Class B (CBHD) FAQ

What is the stock price today?

The current price is €57.52.

On which exchange is it traded?

Coloplast A/S Class B is listed on XDUS.

What is its stock symbol?

The ticker symbol is CBHD.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 9.27%.

What is its market cap?

As of today, no market cap data is available.

Has Coloplast A/S Class B ever had a stock split?

Coloplast A/S Class B had 1 splits and the recent split was on Dec 19, 2012.

Coloplast A/S Class B Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Gavin Wood CEO
XDUS Exchange
DK0060448595 ISIN
DK Country
16,907 Employees
18 May 2026 Last Dividend
19 Dec 2012 Last Split
- IPO Date

Overview

Coloplast A/S, established in 1954 and headquartered in Humlebæk, Denmark, is a leading developer and seller of intimate healthcare products and services internationally. The company's operations span across various countries including Denmark, the United States, the United Kingdom, France, and other global regions. Coloplast A/S's product and service offerings are organized into five key segments: Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care. These offerings target a wide range of medical needs and conditions, emphasizing the company's commitment to enhancing the quality of life for individuals dealing with intimate healthcare challenges.

Products and Services

  • Ostomy Care Products:

    Coloplast offers a range of ostomy care solutions, including SenSura Mio and SenSura, designed for individuals with various types of ostomies. SenSura Mio is noted for its ability to fit individual body shapes and provide optimal discretion. Ostomy accessories are also available under the Brava brand, supporting the comprehensive needs of ostomy patients.

  • Continence Care Products:

    The company's continence care portfolio includes Conveen Active urine bags and SpeediCath catheters, which facilitate easy catheterization for both genders. Additionally, Peristeen Plus stands out as a transanal irrigation system aimed at managing bowel issues.

  • Wound Care Products:

    In the realm of wound care, Coloplast provides Biatain Silicone conforming dressings and Comfeel hydrocolloid dressings, targeted at enhancing the healing process. A variety of skin care products are offered to complement these solutions, such as cleansers, moisturizers, skin protectants, and antifungal products. InterDry, a unique skin fold management solution, addresses further skin care needs.

  • Interventional Urology Products:

    Addressing urological and gynecological disorders, Coloplast develops and markets a suite of products for surgeries related to urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence.

  • Voice and Respiratory Care Solutions:

    The company's voice and respiratory care solutions cater to laryngectomy and tracheostomy patients. The Provox system offers a robust voice prosthesis solution for speaking, alongside HMEs (heat and moisture exchangers), adhesives, tubes for breathing, devices for hands-free speaking, and related accessories. Tracheostomy care products are marketed under the Tracoe brand, supporting the comprehensive needs of individuals with tracheostomies.

Contact Information

Address: Holtedam 1-3
Phone: 45 49 11 11 11